Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs
Senores Pharmaceuticals announced that it has entered into a definitive agreement to acquire 100% equity stake in Apnar Pharma,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Senores Pharmaceuticals
Senores Pharmaceuticals launches Deferiprone Tablets USP in the U.S.
The product will be marketed by Dr Reddy’s Laboratories
Senores Pharmaceuticals receives Philippine FDA approval for 10 products
Company expands presence in Southeast Asia with new regulatory clearances
Senores Pharma forms new subsidiary to strengthen its US footprint
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals LLC, Delaware, USA through subscription of membership…
India levels up in solving complex drug formulation challenges
Chetan Shah highlights how India’s pharmaceutical industry is advancing from bulk drug production to complex formulations,…
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquisition will be funded through the IPO proceeds raised by Senores. This is in line with the Objects of the IPO stated in…
Senores Pharmaceuticals gains ANDA for Enalapril Maleate Tablets 2.5mg, 5mg, 10mg and 20mg from…
Enalapril is indicated as a treatment of hypertension, heart failure, and asymptomatic left ventricular dysfunction
Senores Pharma acquires 14 ANDAs from Dr. Reddy’s
The basket acquired comprises 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
Jubilant Pharma and Aavis Pharma launch Hydroxychloroquine Sulfate tablets in US
The product will be distributed by Jubilant Cadista, a unit of Jubilant Pharma